BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,120,000 | -29.3% | 275,000 | -45.8% | 1.02% | -37.2% |
| Q2 2022 | $25,627,000 | -20.9% | 507,374 | 0.0% | 1.62% | -2.6% |
| Q1 2022 | $32,411,000 | -40.4% | 507,374 | 0.0% | 1.67% | -21.1% |
| Q4 2021 | $54,345,000 | +24.4% | 507,374 | +19.4% | 2.11% | +38.3% |
| Q3 2021 | $43,694,000 | +90.6% | 425,000 | +70.0% | 1.53% | -37.6% |
| Q1 2018 | $22,925,000 | +21.6% | 250,000 | 0.0% | 2.45% | -29.0% |
| Q4 2017 | $18,853,000 | +8.2% | 250,000 | 0.0% | 3.45% | -13.1% |
| Q3 2017 | $17,418,000 | +37.5% | 250,000 | 0.0% | 3.96% | +31.6% |
| Q2 2017 | $12,668,000 | -58.9% | 250,000 | -67.5% | 3.01% | -55.2% |
| Q1 2017 | $30,799,000 | +55.7% | 770,159 | +9.2% | 6.73% | -12.0% |
| Q4 2016 | $19,780,000 | -5.6% | 705,159 | 0.0% | 7.65% | -18.5% |
| Q3 2016 | $20,943,000 | +46.7% | 705,159 | 0.0% | 9.39% | -25.9% |
| Q2 2016 | $14,279,000 | +12.2% | 705,159 | 0.0% | 12.66% | +1.7% |
| Q1 2016 | $12,728,000 | +54.1% | 705,159 | +124.8% | 12.46% | +74.6% |
| Q4 2015 | $8,261,000 | – | 313,626 | – | 7.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |